Average Co-Inventor Count = 12.08
ph-index = 14
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Signal Pharmaceuticals, Inc. (25 from 169 patents)
2. Celgene Corporation (13 from 550 patents)
3. Pharmacopeia Drug Discovery, Inc. (1 from 52 patents)
4. Pharmacopeia Inc. (101 patents)
38 patents:
1. 12404241 - Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith
2. 12227490 - Cereblon binding compounds, compositions thereof, and methods of treatment therewith
3. 12103920 - Cereblon binding compounds, compositions thereof, and methods of treatment therewith
4. 11873283 - Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith
5. 11739075 - Cereblon binding compounds, compositions thereof, and methods of treatment therewith
6. 11634407 - Cereblon binding compounds, compositions thereof, and methods of treatment therewith
7. 11560371 - Cereblon binding compounds, compositions thereof, and methods of treatment therewith
8. 11365184 - Antiproliferative compounds, and their pharmaceutical compositions and uses
9. 11325889 - Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith
10. 11292796 - Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
11. 11149007 - Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith
12. 10683298 - Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
13. 10618883 - Antiproliferative compounds, and their pharmaceutical compositions and uses
14. 10227325 - Antiproliferative compounds, and their pharmaceutical compositions and uses
15. 10167290 - Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors